Anixa Biosciences ANIX

Jump To Section

    $

    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    .
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    +$0.06 (+1.99%)Past DayToday's Volume:
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    ,
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0
    9
    8
    7
    6
    5
    4
    3
    2
    1
    0
    0

    Relative Strength Index (RSI)

    - The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

    - The RSI is calculated using the following formula:

    RSI = 100 - (100 / (1 + RS))

    Where RS is the ratio of the average gains to the average losses over a specified period.

    - The default time period used is 14 days.

    - RSI values range between 0 and 100.

    RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

    RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

    RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

    About

    Business overview of Anixa Biosciences (ANIX)
    Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

    Key Insights

    Critical company metrics and information

    • Latest Closing Price

      $2.84

    • Market Cap

      $91.44 Million

    • Price-Earnings Ratio

      -7.28

    • Total Outstanding Shares

      32.20 Million Shares

    • Total Employees

      5

    • Dividend

      No dividend

    • IPO Date

      April 12, 1989

    • SIC Description

      Pharmaceutical Preparations

    • Primary Exchange

      NASDAQ

    • Type

      Common Stock

    • Headquarters

      3150 almaden expressway, suite 250, San jose, CA, 95118

    • Homepage

      https://www.anixa.com

    Historical Stock Splits

    Execution DateSplit Amount
    No Historical Stock Splits

    Cash Flow Statement

    November 1, 2023 to October 31, 2024
    MetricValue
    Net Cash Flow$356,000
    Net Cash Flow From Operating Activities, Continuing$-7.33 Million
    Net Cash Flow From Financing Activities, Continuing$3.42 Million
    Net Cash Flow From Investing Activities$4.28 Million
    Net Cash Flow, Continuing$356,000
    Net Cash Flow From Investing Activities, Continuing$4.28 Million

    Income Statement

    November 1, 2023 to October 31, 2024
    MetricValue
    Net Income/Loss Attributable To Noncontrolling Interest$-144,000
    Operating Income/Loss$-13.83 Million
    Operating Expenses$14.04 Million
    Diluted Earnings Per Share$-0.39
    Costs And Expenses$13.83 Million
    Basic Earnings Per Share$-0.39

    Comprehensive Income

    November 1, 2023 to October 31, 2024
    MetricValue
    Comprehensive Income/Loss Attributable To Parent$-12.70 Million
    Other Comprehensive Income/Loss$0
    Comprehensive Income/Loss$-12.70 Million
    Comprehensive Income/Loss Attributable To Noncontrolling Interest$0

    Balance Sheet

    November 1, 2023 to October 31, 2024
    MetricValue
    Other Current Assets$21.19 Million
    Current Assets$21.36 Million
    Noncurrent Assets$229,000
    Accounts Payable$525,000
    Current Liabilities$2.50 Million
    Accounts Receivable$173,000

    Historical Dividends

    Announcement DatePayment DateRecord DateAmountFrequency
    No historical dividends

    Recent Headlines From The Web

    Latest news, press releases, and media coverage about ANIX from trusted financial sources
      Boost your savings and earn 4.15% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
      All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

      ⓒ 2025 Financhle. All Rights Reserved.